Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14 , 1510.

Selinde Sterre WindManon A A JansenMelanie RijsbergenMichiel J van EsdonkDimitrios ZiagkosWing C ChengTessa Niemeyer-van der KolkJohn KorstenAgnieszka GruszkaDebora Schmitz-RohmerDavid BonnelRaphael LegouffeFlorian BarréMarcel W BekkenkEllen R M de HaasKoen D QuintHarald SchnidarMelanie RolliHenk Johan Streefkerk Jacobus Burggraaf Maarten H VermeerRobert Rissmann

Published in: Cancers (2023)

The authors wish to make the following corrections to this paper [...].

Keyphrases

randomized controlled trial
end stage renal disease
endothelial cells
chronic kidney disease
newly diagnosed
prognostic factors
emergency department
clinical trial
induced pluripotent stem cells
patient reported outcomes
adverse drug
meta analyses